Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1333 to 1382 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL34\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l34, mitochondrial precursor (l34mt). [source:swissprot;acc:q9bq48]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.78\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02271\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRAF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
jm4 protein. [source:refseq;acc:nm\_007213]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.643\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02264\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARL6IP5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytoskeleton related vitamin a responsive protein; glutamate transporter eeac1-associated protein; dermal papilla derived protein 11; putative mapk activating protein pm27. [source:refseq;acc:nm\_006407]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.287\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GALK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-acetylgalactosamine kinase (ec 2.7.1.-) (galnac kinase) (galactokinase 2). [source:swissprot;acc:q01415]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.162\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
210.412\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02257\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GALE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
udp-glucose 4-epimerase (ec 5.1.3.2) (galactowaldenase) (udp- galactose 4-epimerase). [source:swissprot;acc:q14376]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NPC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.204\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02239\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SUV39H2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 2 (ec 2.1.1.43) (histone h3-k9 methyltransferase 2) (h3-k9-hmtase 2) (suppressor of variegation 3-9 homolog 2) (su(var)3-9 homolog 2). [source:swissprot;acc:q9h5i1]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.433\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
231.491\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02234\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF2S1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 1 (eukaryotic translation initiation factor 2 alpha subunit) (eif-2-alpha) (eif- 2alpha) (eif-2a). [source:swissprot;acc:p05198]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SUV39H1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 1 (ec 2.1.1.43) (histone h3-k9 methyltransferase 1) (h3-k9-hmtase 1) (suppressor of variegation 3-9 homolog 1) (su(var)3-9 homolog 1). [source:swissprot;acc:o43463]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC25A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
m-phase inducer phosphatase 1 (ec 3.1.3.48) (dual specificity phosphatase cdc25a). [source:swissprot;acc:p30304]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
258.558\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
252.916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
exonuclease 1 isoform b; rad2 nuclease family member, homolog of s. cerevisiae exonuclease 1. [source:refseq;acc:nm\_006027]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.772\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
221.594\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02224\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FANCL\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phd finger protein 9. [source:refseq;acc:nm\_018062]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SOLH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
small optic lobes homolog; small optic lobes, drosophila, homolog of. [source:refseq;acc:nm\_005632]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIAS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipoic acid synthetase, mitochondrial (lip-syn) (lipoate synthase) (hussy-01) (fragment). [source:swissprot;acc:o43766]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.517\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02223\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 1 (zinc finger protein of the cerebellum 1). [source:swissprot;acc:q15915]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.569\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02215\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 3 (zinc finger protein of the cerebellum 3). [source:swissprot;acc:o60481]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.572\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.841\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZIC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein zic 2 (zinc finger protein of the cerebellum 2). [source:swissprot;acc:o95409]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.574\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.847\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
prohibitin. [source:swissprot;acc:p35232]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.513\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
206.941\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02209\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparin sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.-) (n- hsst) (n-heparin sulfate sulfotransferase) (glucosaminyl n- deacetylase/n-sulfotransferase). [source:swissprot;acc:p52849]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.409\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
223.475\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02208\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-deacetylase/n-sulfotransferase (heparan glucosaminyl) 3. [source:refseq;acc:nm\_004784]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
n-deacetylase/n-sulfotransferase 4. [source:refseq;acc:nm\_022569]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDST1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heparan sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.8) (n-hsst) (hsnst) ([heparan sulfate]-glucosamine n-sulfotransferase) (n-heparan sulfate sulfotransferase) (glucosaminyl n-deacetylase/n- sulfotransferase). [source:swissprot;acc:p52848]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC27\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cdc27hs (cell division cycle protein 27 homolog) (h-nuc). [source:swissprot;acc:p30260]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
USF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
upstream stimulatory factor 1 (major late transcription factor 1). [source:swissprot;acc:p22415]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.987\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.359\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.022\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTT2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.726\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02197\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TGFBR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tgf-beta receptor type i precursor (ec 2.7.1.37) (tgfr-1) (tgf-beta type i receptor) (serine/threonine-protein kinase receptor r4) (skr4) (activin receptor-like kinase 5) (alk-5). [source:swissprot;acc:p36897]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.805\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02195\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
USF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
upstream stimulatory factor 2 (upstream transcription factor 2) (fos-interacting protein) (fip) (major late transcription factor 2). [source:swissprot;acc:q15853]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.971\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.354\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAOX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.736\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02194\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CREB5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp response element-binding protein cre-bpa. [source:refseq;acc:nm\_004904]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.591\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.899\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACVR1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase receptor r2 precursor (ec 2.7.1.37) (skr2) (activin receptor-like kinase 4) (alk-4) (actr-ib). [source:swissprot;acc:p36896]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.797\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATPIF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atpase inhibitor, mitochondrial precursor. [source:swissprot;acc:q9uii2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.736\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACVR1C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
activin a receptor, type ic; activin receptor-like kinase 7. [source:refseq;acc:nm\_145259]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.795\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FREQ\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuronal calcium sensor 1 (ncs-1) (frequenin homolog) (frequenin-like protein) (frequenin-like ubiquitous protein). [source:swissprot;acc:p36610]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
228.799\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SMOX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polyamine oxidase isoform 1; polyamine oxidase; flavin-containing spermine oxidase; putative cyclin g1 interacting protein; flavin containing amine oxidase. [source:refseq;acc:nm\_019025]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.644\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
223.736\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HCCS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome c-type heme lyase (ec 4.4.1.17) (cchl) (holocytochrome c- type synthase). [source:swissprot;acc:p53701]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NCK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytoplasmic protein nck1 (nck adaptor protein 1) (sh2/sh3 adaptor protein nck-alpha). [source:swissprot;acc:p16333]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
200.784\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02192\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GSTT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutathione s-transferase theta 1 (ec 2.5.1.18) (gst class-theta) (glutathione transferase t1-1). [source:swissprot;acc:p30711]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.744\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02191\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SOCS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
suppressor of cytokine signaling 1 (socs-1) (jak-binding protein) (jab) (stat induced stat inhibitor 1) (ssi-1) (tec-interacting protein 3) (tip-3). [source:swissprot;acc:o15524]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.542\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
211.908\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02187\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GMFG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glia maturation factor gamma (gmf-gamma). [source:swissprot;acc:o60234]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ASCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
asc-1 complex subunit p100. [source:refseq;acc:nm\_032204]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FKBP1A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fk506-binding protein 1a (ec 5.2.1.8) (peptidyl-prolyl cis-trans isomerase) (ppiase) (rotamase) (12 kda fkbp) (fkbp-12) (immunophilin fkbp12). [source:swissprot;acc:p20071]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EYA3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eyes absent homolog 3. [source:swissprot;acc:q99504]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SALL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sal-like protein 2 (zinc finger protein sall2) (hsal2). [source:swissprot;acc:q9y467]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.471\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.876\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02148\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SALL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sal-like protein 3 (zinc finger protein sall3) (hsall3). [source:swissprot;acc:q9bxa9]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.47\vspace{3pt}}}&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RERE\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginine-glutamic acid dipeptide (re) repeats; atrophin 1-like; arginine glutamic acid dipeptide re repeats. [source:refseq;acc:nm\_012102]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
213.875\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
USP8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin carboxyl-terminal hydrolase 8 (ec 3.1.2.15) (ubiquitin thiolesterase 8) (ubiquitin-specific processing protease 8) (deubiquitinating enzyme 8). [source:swissprot;acc:p40818]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
213.876\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ROD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rod1 regulator of differentiation 1; fission yeast differentiation regulator; regulator of differentiation (in s. pombi) 1; regulator of differentiation (in s. pombe) 1. [source:refseq;acc:nm\_005156]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PTBP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polypyrimidine tract binding protein 2; neural polypyrimidine tract binding protein; ptb-like protein. [source:refseq;acc:nm\_021190]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/